A Randomized Crossover Oral Bioavailability Study Comparing the Pharmacokinetics and Pharmacodynamics of Picoplatin Administered Orally With Picoplatin Administered Intravenously in Subjects With Advanced Non-Hematological Malignancies.

Trial Profile

A Randomized Crossover Oral Bioavailability Study Comparing the Pharmacokinetics and Pharmacodynamics of Picoplatin Administered Orally With Picoplatin Administered Intravenously in Subjects With Advanced Non-Hematological Malignancies.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Aug 2009

At a glance

  • Drugs Picoplatin; Picoplatin
  • Indications Cancer; Solid tumours
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 25 Aug 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
    • 21 Apr 2009 Final results have been reported at the 100th Annual Meeting of the American Association for Cancer Research (AACR-2009)
    • 18 Nov 2008 Final top-line results reported in a Poniard media release. Endpoints achieved.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top